An open trial of clozapine for dystonia
Identifieur interne : 004E14 ( Main/Exploration ); précédent : 004E13; suivant : 004E15An open trial of clozapine for dystonia
Auteurs : Barbara Illowsky Karp [Canada] ; Susanne R. Goldstein [Canada] ; Robert Chen [Canada] ; Ali Samii [États-Unis] ; William Bara-Jimenez [Canada] ; Mark Hallett [Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 1999-07.
English descriptors
- KwdEn :
Abstract
Pharmacologic treatment of severe dystonia is often unsatisfactory. The atypical antipsychotic medication clozapine appears to improve tardive dystonia associated with conventional neuroleptic use. We studied the efficacy of clozapine for severe dystonia in five patients in an open trial. The patient cohort included four with generalized dystonia and one with Meige syndrome. All patients were evaluated at baseline and at least weekly while on medication with subjective assessment of response by the patient and physician rating using the Burke‐Fahn‐Marsden Evaluation Scale for Dystonia. All five subjects had significant improvement detected by the Burke‐Fahn‐Marsden Evaluation Scale as well as subjective improvement while on clozapine. Side effects, such as sedation and orthostatic hypotension, developed in all patients but was only treatment‐limiting in one subject who developed persistent symptomatic orthostatic hypotension and tachycardia. Two of the four remaining patients continued clozapine after completion of the study; an additional patient was uncertain if the benefit outweighed the side effects. One patient discontinued treatment because of difficulty obtaining the FDA‐required weekly white blood cell counts for patients on clozapine. We conclude that clozapine appears to be effective for generalized and refractory focal dystonia although its use may be limited by the side effects and need for hematologic monitoring.
Url:
DOI: 10.1002/1531-8257(199907)14:4<652::AID-MDS1015>3.0.CO;2-G
Affiliations:
- Canada, États-Unis
- Ontario, Washington (État)
- Seattle, Toronto
- Université de Toronto, Université de Washington
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001B87
- to stream Istex, to step Curation: 001B87
- to stream Istex, to step Checkpoint: 003581
- to stream Main, to step Merge: 007B13
- to stream Main, to step Curation: 004E14
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">An open trial of clozapine for dystonia</title><author><name sortKey="Illowsky Karp, Barbara" sort="Illowsky Karp, Barbara" uniqKey="Illowsky Karp B" first="Barbara" last="Illowsky Karp">Barbara Illowsky Karp</name></author><author><name sortKey="Goldstein, Susanne R" sort="Goldstein, Susanne R" uniqKey="Goldstein S" first="Susanne R." last="Goldstein">Susanne R. Goldstein</name></author><author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name></author><author><name sortKey="Samii, Ali" sort="Samii, Ali" uniqKey="Samii A" first="Ali" last="Samii">Ali Samii</name></author><author><name sortKey="Bara Imenez, William" sort="Bara Imenez, William" uniqKey="Bara Imenez W" first="William" last="Bara-Jimenez">William Bara-Jimenez</name></author><author><name sortKey="Hallett, Mark" sort="Hallett, Mark" uniqKey="Hallett M" first="Mark" last="Hallett">Mark Hallett</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6D20F7F052C62E22F21F347CFAC305F19CF1227B</idno><date when="1999" year="1999">1999</date><idno type="doi">10.1002/1531-8257(199907)14:4<652::AID-MDS1015>3.0.CO;2-G</idno><idno type="url">https://api.istex.fr/document/6D20F7F052C62E22F21F347CFAC305F19CF1227B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001B87</idno><idno type="wicri:Area/Istex/Curation">001B87</idno><idno type="wicri:Area/Istex/Checkpoint">003581</idno><idno type="wicri:doubleKey">0885-3185:1999:Illowsky Karp B:an:open:trial</idno><idno type="wicri:Area/Main/Merge">007B13</idno><idno type="wicri:Area/Main/Curation">004E14</idno><idno type="wicri:Area/Main/Exploration">004E14</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">An open trial of clozapine for dystonia</title><author><name sortKey="Illowsky Karp, Barbara" sort="Illowsky Karp, Barbara" uniqKey="Illowsky Karp B" first="Barbara" last="Illowsky Karp">Barbara Illowsky Karp</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A.; University of Toronto, The Toronto Hospital, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Goldstein, Susanne R" sort="Goldstein, Susanne R" uniqKey="Goldstein S" first="Susanne R." last="Goldstein">Susanne R. Goldstein</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A.; University of Toronto, The Toronto Hospital, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A.; University of Toronto, The Toronto Hospital, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Samii, Ali" sort="Samii, Ali" uniqKey="Samii A" first="Ali" last="Samii">Ali Samii</name><affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Washington, Seattle, Washington</wicri:regionArea><placeName><region type="state">Washington (État)</region><settlement type="city">Seattle</settlement></placeName><orgName type="university">Université de Washington</orgName></affiliation></author><author><name sortKey="Bara Imenez, William" sort="Bara Imenez, William" uniqKey="Bara Imenez W" first="William" last="Bara-Jimenez">William Bara-Jimenez</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A.; University of Toronto, The Toronto Hospital, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Hallett, Mark" sort="Hallett, Mark" uniqKey="Hallett M" first="Mark" last="Hallett">Mark Hallett</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A.; University of Toronto, The Toronto Hospital, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="1999-07">1999-07</date><biblScope unit="vol">14</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="652">652</biblScope><biblScope unit="page" to="657">657</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6D20F7F052C62E22F21F347CFAC305F19CF1227B</idno><idno type="DOI">10.1002/1531-8257(199907)14:4<652::AID-MDS1015>3.0.CO;2-G</idno><idno type="ArticleID">MDS1015</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Basal ganglia</term><term>Clozapine</term><term>Dopamine</term><term>Dystonia</term><term>Torticollis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Pharmacologic treatment of severe dystonia is often unsatisfactory. The atypical antipsychotic medication clozapine appears to improve tardive dystonia associated with conventional neuroleptic use. We studied the efficacy of clozapine for severe dystonia in five patients in an open trial. The patient cohort included four with generalized dystonia and one with Meige syndrome. All patients were evaluated at baseline and at least weekly while on medication with subjective assessment of response by the patient and physician rating using the Burke‐Fahn‐Marsden Evaluation Scale for Dystonia. All five subjects had significant improvement detected by the Burke‐Fahn‐Marsden Evaluation Scale as well as subjective improvement while on clozapine. Side effects, such as sedation and orthostatic hypotension, developed in all patients but was only treatment‐limiting in one subject who developed persistent symptomatic orthostatic hypotension and tachycardia. Two of the four remaining patients continued clozapine after completion of the study; an additional patient was uncertain if the benefit outweighed the side effects. One patient discontinued treatment because of difficulty obtaining the FDA‐required weekly white blood cell counts for patients on clozapine. We conclude that clozapine appears to be effective for generalized and refractory focal dystonia although its use may be limited by the side effects and need for hematologic monitoring.</div></front></TEI><affiliations><list><country><li>Canada</li><li>États-Unis</li></country><region><li>Ontario</li><li>Washington (État)</li></region><settlement><li>Seattle</li><li>Toronto</li></settlement><orgName><li>Université de Toronto</li><li>Université de Washington</li></orgName></list><tree><country name="Canada"><region name="Ontario"><name sortKey="Illowsky Karp, Barbara" sort="Illowsky Karp, Barbara" uniqKey="Illowsky Karp B" first="Barbara" last="Illowsky Karp">Barbara Illowsky Karp</name></region><name sortKey="Bara Imenez, William" sort="Bara Imenez, William" uniqKey="Bara Imenez W" first="William" last="Bara-Jimenez">William Bara-Jimenez</name><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name><name sortKey="Goldstein, Susanne R" sort="Goldstein, Susanne R" uniqKey="Goldstein S" first="Susanne R." last="Goldstein">Susanne R. Goldstein</name><name sortKey="Hallett, Mark" sort="Hallett, Mark" uniqKey="Hallett M" first="Mark" last="Hallett">Mark Hallett</name></country><country name="États-Unis"><region name="Washington (État)"><name sortKey="Samii, Ali" sort="Samii, Ali" uniqKey="Samii A" first="Ali" last="Samii">Ali Samii</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E14 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E14 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6D20F7F052C62E22F21F347CFAC305F19CF1227B
|texte= An open trial of clozapine for dystonia
}}
| This area was generated with Dilib version V0.6.23. |  |